Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
29 studies found for:    Lyme disease | "Borrelia Infections"
Show Display Options
Rank Status Study
21 Completed Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Conditions: Relapsing Fever, Tick-Borne;   Jarisch Herxheimer Reaction
Intervention: Drug: doxycycline treatment
22 Recruiting Antibiotic Treatment of Multiple Erythema Migrans
Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone;   Drug: doxycycline;   Other: erythema migrans patients treated with doxycycline
23 Unknown  Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
Condition: Suspected Early Lyme Neuroborreliosis
Interventions: Drug: doxycycline;   Drug: ceftriaxone
24 Recruiting Cytokines and Chemokines in Erythema Migrans
Condition: Erythema Migrans
Intervention: Drug: antibiotic treatment
25 Completed
Has Results
Duration of Antibiotic Treatment of Erythema Migrans
Condition: Erythema Chronicum Migrans
Interventions: Drug: doxycycline;   Drug: placebo
26 Not yet recruiting Study of Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Doxycycline;   Drug: Ceftriaxone
27 Completed Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Ceftriaxone;   Drug: Doxycycline
28 Recruiting Laboratory Characteristics in Chronic Atrophic Acrodermatitis
Condition: Chronic Atrophic Acrodermatitis
Interventions: Drug: doxycycline orally, 100 mg, bid, 14 days;   Drug: doxycycline orally, 100 mg, bid, 28 days
29 Completed Microbiologic Findings of Acute Facial Palsy in Children
Condition: Facial Paralysis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-29) Next Page   
Indicates status has not been verified in more than two years